Evidence map›Paper›PMID 42990939›Full record

ReviewFrontiers in immunology2026

Gut microbiota-bone marrow axis: how intestinal signals remodel hematopoiesis and immune status.

Xuemin Chen, Xuemei Li, Yulong Song, Xuan Liu, Jun Li

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xuemin Chen *Department of Gastroenterology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
Xuemei Li *Department of Gastroenterology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
Yulong SongDepartment of Gastroenterology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
Xuan LiuDepartment of Gastroenterology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
Jun LiDepartment of Gastroenterology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiota, as a complex ecological system within the host, plays a critical role not only in regulating local intestinal immunity and metabolism but also in influencing hematopoietic stem cell (HSC) function and immune cell lineage differentiation through the gut-bone marrow axis. This review comprehensively examines how the gut microbiota remodels hematopoiesis and immune status via multiple mechanisms, particularly by modulating systemic inflammation, the bone marrow microenvironment, and HSC fate decisions. Special emphasis is placed on the role of Toll-like receptor (TLR) signaling pathways in linking the gut microbiota to bone metabolism and immune regulation. The review also integrates recent insights from single-cell sequencing technologies that reveal hematopoietic lineage biases in the bone marrow and explores the development and immune memory of gut-associated B cell populations during early life. By systematically synthesizing recent advances in the interaction between gut microbiota and bone marrow hematopoiesis, this article aims to provide a theoretical foundation for understanding how gut microbiota regulate systemic immune homeostasis and bone metabolism and to identify potential therapeutic targets for future interventions.

Indexed as

Bone MarrowGastrointestinal MicrobiomeHematopoiesisIntestinesAnimalsHematopoietic Stem CellsHumansSignal TransductionToll-Like ReceptorsToll-Like Receptorsbone marrow axisbone metabolismgut microbiotahematopoietic stem cellsimmune regulationsystemic inflammationtoll-like receptors

Identifiers

PMID42990939
PMCPMC13735792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.